A detailed history of Cubist Systematic Strategies, LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 29,189 shares of MGTX stock, worth $189,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,189
Previous 24,180 20.72%
Holding current value
$189,144
Previous $101,000 19.8%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.88 - $5.23 $19,434 - $26,197
5,009 Added 20.72%
29,189 $121,000
Q2 2024

Aug 14, 2024

SELL
$4.21 - $5.81 $57,213 - $78,957
-13,590 Reduced 35.98%
24,180 $101,000
Q1 2024

May 15, 2024

BUY
$5.78 - $7.33 $136,286 - $172,834
23,579 Added 166.15%
37,770 $229,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $51,087 - $101,465
14,191 New
14,191 $99,000
Q1 2023

May 15, 2023

SELL
$5.04 - $8.6 $29,095 - $49,647
-5,773 Reduced 39.06%
9,007 $46,000
Q4 2022

Feb 14, 2023

BUY
$5.8 - $8.98 $2,644 - $4,094
456 Added 3.18%
14,780 $96,000
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $18,927 - $28,203
-2,507 Reduced 14.9%
14,324 $120,000
Q2 2022

Aug 15, 2022

SELL
$6.8 - $14.23 $74,718 - $156,359
-10,988 Reduced 39.5%
16,831 $127,000
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $82,814 - $144,277
6,171 Added 28.51%
27,819 $385,000
Q4 2021

Feb 14, 2022

BUY
$12.78 - $23.74 $276,661 - $513,923
21,648 New
21,648 $514,000
Q2 2019

Aug 14, 2019

SELL
$17.38 - $26.88 $60,239 - $93,166
-3,466 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $31,887 - $73,513
3,466 New
3,466 $60,000
Q3 2018

Nov 14, 2018

SELL
$8.1 - $13.6 $65,124 - $109,344
-8,040 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$11.2 - $15.0 $90,048 - $120,600
8,040 New
8,040 $92,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.